(Q39629849)

13 September 2017

title

Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by oridonin nanosuspension (English)

1 reference

13 September 2017

Fei-Fei Feng

1

1 reference

13 September 2017

Dian-Rui Zhang

2

1 reference

13 September 2017

Ke-Li Tian

3

1 reference

13 September 2017

Hai-Yan Lou

4

1 reference

13 September 2017

Xiao-Li Qi

5

1 reference

13 September 2017

Yan-Cai Wang

6

1 reference

13 September 2017

Cun-Xian Duan

7

1 reference

13 September 2017

Le-Jiao Jia

8

1 reference

13 September 2017

Fei-Hu Wang

9

1 reference

13 September 2017

Yue Liu

10

1 reference

13 September 2017

Qiang Zhang

11

1 reference

13 September 2017

language of work or name

English

0 references

publication date

24 November 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

18

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

265-271

1 reference

P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.536271

Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.536271

Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.536271

Effects of paclitaxel with or without cremophor EL on cellular clonogenic survival and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.536271

Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.536271

Nanosizing--oral formulation development and biopharmaceutical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.536271

Role of caspase 3-dependent Bcl-2 cleavage in potentiation of apoptosis by Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.536271

Solid lipid nanoparticles: production, characterization and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.536271

Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.536271

Caspases: killer proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.536271

Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.536271

Bcl-2 family: life-or-death switch

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.536271

Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.536271

Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.536271

10.3109/10717544.2010.536271

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference